[{"question": "Preferred vein for central venous catheter inseion is", "correct_answer": "Right internal jugular vein", "correct_idx": 0, "options": ["A)Right internal jugular vein", "B)Left internal jugular vein", "C)Right subclan vein", "D)Right antecubital vein"], "prompt": "Preferred vein for central venous catheter inseion isA)Right internal jugular vein\nB)Left internal jugular vein\nC)Right subclan vein\nD)Right antecubital vein", "subject_name": "Medicine", "output0": "The right internal jugular vein is the preferred vein for central venous catheterization in children because it is larger and more accessible than other veins, such as the left internal jugular vein or the subclavian vein. Additionally, the right internal jugular vein is less likely to be blocked by the sternum or ribs, which can make insertion more difficult.\n\n", "output1": "The left internal jugular vein is the preferred site for central venous catheter insertion because it is located near the heart and has a lower risk of complications such as pneumothorax or hemothorax compared to the right internal jugular vein.\n\n", "output2": "The right subclavian vein is the preferred vein for central venous catheterization because it is located near the heart and is easily accessible. Additionally, it is less likely to be affected by respiratory movements, which can make catheterization more challenging.\n\n", "output3": "The right antecubital vein is the preferred vein for central venous catheterization in children because it is easily accessible, has a low risk of complications, and allows for easy monitoring of the catheter.\n\n"}, {"question": "Amide group is present in which pa of protein -", "correct_answer": "Peptide bond", "correct_idx": 2, "options": ["A)Amino-terminal", "B)Carboxy-terminal", "C)Peptide bond", "D)Disulfide bond"], "prompt": "Amide group is present in which pa of protein -A)Amino-terminal\nB)Carboxy-terminal\nC)Peptide bond\nD)Disulfide bond", "subject_name": "Biochemistry", "output0": "The amide group is present in the amino-terminal part of a protein. This group is formed when the carboxyl group of one amino acid reacts with the amino group of another amino acid to form a peptide bond.\n\n", "output1": "The amide group is present in the carboxy-terminal part of a protein. This group is formed when the carboxyl group of an amino acid is bonded to the amino group of another amino acid through a peptide bond.\n\n", "output2": "The amide group is present in the peptide bond, which is a chemical bond that links two amino acids together in a protein. The peptide bond is formed when the carbonyl group of one amino acid reacts with the amino group of another amino acid.\n\n", "output3": "The amide group is present in the peptide bond, which is the link between two amino acids in a protein.\n\n"}, {"question": "Ipsilateral third nerve lesion & contralateral hemiplegia seen in?", "correct_answer": "Weber syndrome", "correct_idx": 0, "options": ["A)Weber syndrome", "B)Parinaud syndrome", "C)Foville syndrome", "D)Wallenburg syndrome"], "prompt": "Ipsilateral third nerve lesion & contralateral hemiplegia seen in?A)Weber syndrome\nB)Parinaud syndrome\nC)Foville syndrome\nD)Wallenburg syndrome", "subject_name": "Unknown", "output0": "An ipsilateral third nerve lesion and contralateral hemiplegia are both signs of Weber syndrome, a rare condition that is characterized by a combination of oculomotor and abducens nerve palsies.\n\n", "output1": "Parinaud syndrome is a rare condition that is characterized by ipsilateral third nerve lesion and contralateral hemiplegia. This condition is often seen in children and young adults, and is caused by a lesion in the brainstem.\n\n", "output2": "Foville syndrome is characterized by ipsilateral third nerve lesion and contralateral hemiplegia, which is seen in children.\n\n", "output3": "Wallenburg syndrome is characterized by ipsilateral third nerve lesion and contralateral hemiplegia. This syndrome is caused by a lesion in the brainstem, specifically in the medial longitudinal fasciculus, which results in a combination of ipsilateral third nerve palsy and contralateral hemiparesis.\n\n"}, {"question": "Which of the following side effects is NOT characteristic of opioid drugs ?:", "correct_answer": "Increase in diuresis.", "correct_idx": 0, "options": ["A)Increase in diuresis.", "B)Constipation.", "C)Drowsiness.", "D)Nausea and vomiting."], "prompt": "Which of the following side effects is NOT characteristic of opioid drugs ?:A)Increase in diuresis.\nB)Constipation.\nC)Drowsiness.\nD)Nausea and vomiting.", "subject_name": "pharmacology", "output0": "Opioid drugs are known to cause constipation, drowsiness, and nausea and vomiting, but they do not typically cause an increase in diuresis (increased urine production).\n\n", "output1": "Opioid drugs typically cause constipation, but this is not a side effect.\n\n", "output2": "Drowsiness is not a characteristic side effect of opioid drugs. Opioids are known to cause constipation, increase in diuresis, and nausea and vomiting, but they do not typically cause drowsiness.\n\n", "output3": "Nausea and vomiting are not characteristic side effects of opioid drugs. Opioids are known to cause constipation, increase in diuresis, and drowsiness.\n\n"}, {"question": "Which of these interleukins is not associated with stimulating the proliferation and differentiation of lymphocytes?", "correct_answer": "IL-1", "correct_idx": 0, "options": ["A)IL-1", "B)IL-2", "C)IL-4", "D)IL-12"], "prompt": "Which of these interleukins is not associated with stimulating the proliferation and differentiation of lymphocytes?A)IL-1\nB)IL-2\nC)IL-4\nD)IL-12", "subject_name": "Unknown", "output0": "IL-1 is not associated with stimulating the proliferation and differentiation of lymphocytes. In fact, IL-1 has been shown to inhibit the proliferation of lymphocytes. The other options, IL-2, IL-4, and IL-12, are all known to promote the proliferation and differentiation of lymphocytes.\n\n", "output1": "IL-2 is not associated with stimulating the proliferation and differentiation of lymphocytes. Instead, it is involved in the activation and proliferation of T cells.\n\n", "output2": "IL-4 is not associated with stimulating the proliferation and differentiation of lymphocytes. Instead, it is involved in the regulation of immune responses and the development of T-cells. The other interleukins listed (IL-1, IL-2, and IL-12) are all involved in the proliferation and differentiation of lymphocytes.\n\n", "output3": "IL-12 is an interleukin that is involved in the regulation of the immune response, but it does not stimulate the proliferation and differentiation of lymphocytes. The other options, IL-1, IL-2, and IL-4, are all interleukins that are involved in the regulation of the immune response and do stimulate the proliferation and differentiation of lymphocytes.\n\n"}, {"question": "Artery of 4th pharyngeal arch:", "correct_answer": "Right and left subclavian artery and arch of aorta.", "correct_idx": 1, "options": ["A)Right and left CCA.", "B)Right and left subclavian artery and arch of aorta.", "C)Right and left pulmonary arteries.", "D)None of the above."], "prompt": "Artery of 4th pharyngeal arch:A)Right and left CCA.\nB)Right and left subclavian artery and arch of aorta.\nC)Right and left pulmonary arteries.\nD)None of the above.", "subject_name": "Anatomy", "output0": "The artery of the 4th pharyngeal arch gives rise to the right and left common carotid arteries (CCAs), which are the main branches of the aortic arch.\n\n", "output1": "The 4th pharyngeal arch gives rise to the right and left subclavian arteries, which are the first branches of the aortic arch.\n\n", "output2": "The 4th pharyngeal arch gives rise to the right and left pulmonary arteries.\n\n", "output3": "The artery of the 4th pharyngeal arch does not exist. The 4th pharyngeal arch is a part of the development of the throat and is not connected to the circulatory system.\n\n"}, {"question": "The advantage of metal base denture is:", "correct_answer": "Increase in tissue tolerance", "correct_idx": 0, "options": ["A)Increase in tissue tolerance", "B)Easy laboratory procedure", "C)Rebasing and relining are quite easy", "D)Increase in restorative cost"], "prompt": "The advantage of metal base denture is:A)Increase in tissue tolerance\nB)Easy laboratory procedure\nC)Rebasing and relining are quite easy\nD)Increase in restorative cost", "subject_name": "Dental", "output0": "The metal base denture provides a more stable foundation for the denture, which allows for better tissue tolerance and a more comfortable fit for the patient. Additionally, the metal base can be adjusted to fit the patient's mouth more accurately, which can increase the longevity of the denture.\n\n", "output1": "The metal base denture is easier to work with in the laboratory, as it allows for more precise and accurate fabrication. This results in a more predictable fit and a better final product.\n\n", "output2": "The metal base denture is easier to rebase and reline compared to acrylic dentures. This is because metal is a more durable material that can withstand the wear and tear of the denture-bearing surface without losing its shape or integrity.\n\n", "output3": "The advantage of metal base dentures is that they are more costly to produce than other types of dentures. This is because metal is a more expensive material than acrylic, which is commonly used in denture fabrication.\n\n"}, {"question": "Use the following major clinical side effects of the drug in whichever class lupus symptoms?", "correct_answer": "procainamide", "correct_idx": 3, "options": ["A)sotalol", "B)disopyramide", "C)amiodarone", "D)procainamide"], "prompt": "Use the following major clinical side effects of the drug in whichever class lupus symptoms?A)sotalol\nB)disopyramide\nC)amiodarone\nD)procainamide", "subject_name": null, "output0": "Sotalol is a beta blocker that is commonly used to treat certain types of heart rhythm disorders. One of the major clinical side effects of sotalol is bronchospasm, which can be particularly problematic for individuals with lupus, as they are at increased risk for respiratory complications. Therefore, sotalol should be used with caution in patients with lupus.\n\n", "output1": "Disopyramide is a drug that is commonly used to treat certain types of lupus symptoms, such as arthritis, fever, and skin rashes. One of the major clinical side effects of disopyramide is an increased risk of liver damage.\n\n", "output2": "Amiodarone is a class III antiarrhythmic drug that is commonly used to treat various cardiac arrhythmias. One of the major clinical side effects of amiodarone is thyroid dysfunction, which can be a significant concern for patients with lupus, as they are more susceptible to thyroid disorders.\n\n", "output3": "Procainamide is an anti-arrhythmic drug that is commonly used to treat lupus-related heart rhythm disorders, such as atrial fibrillation and ventricular tachycardia. It is also used to treat other autoimmune diseases, such as rheumatoid arthritis and Sjogren's syndrome.\n\n"}, {"question": "Mrs. J.L.G., blood group A Rh negative, has been the mother of two twins, one of them Rh positive and the other A Rh negative). What dose of anti-D gammaglobulin should be administered to this patient taking into account that she did not receive a prophylactic dose between weeks 28 and 30 of gestation ?:", "correct_answer": "300 micrograms.", "correct_idx": 3, "options": ["A)900 micrograms.", "B)800 micrograms.", "C)600 micrograms.", "D)300 micrograms."], "prompt": "Mrs. J.L.G., blood group A Rh negative, has been the mother of two twins, one of them Rh positive and the other A Rh negative). What dose of anti-D gammaglobulin should be administered to this patient taking into account that she did not receive a prophylactic dose between weeks 28 and 30 of gestation ?:A)900 micrograms.\nB)800 micrograms.\nC)600 micrograms.\nD)300 micrograms.", "subject_name": "nursery", "output0": "The dose of anti-D gammaglobulin for a patient like Mrs. J.L.G. should be 900 micrograms, as she is Rh negative and one of her twins is Rh positive. This dose is recommended to prevent the development of anti-D antibodies in the mother's blood, which could lead to hemolytic disease of the newborn.\n\n", "output1": "The recommended dose of anti-D gammaglobulin for a patient like Mrs. J.L.G. who did not receive a prophylactic dose between weeks 28 and 30 of gestation is 800 micrograms. This is based on the fact that she has a Rh-negative blood type and one of her twins is Rh positive.\n\n", "output2": "The recommended dose of anti-D gammaglobulin for a patient like Mrs. J.L.G. who did not receive a prophylactic dose between weeks 28 and 30 of gestation is 600 micrograms. This dose is intended to prevent the development of hemolytic disease of the newborn.\n\n", "output3": "The recommended dose of anti-D gammaglobulin for a patient like Mrs. J.L.G. who did not receive a prophylactic dose between weeks 28 and 30 of gestation is 300 micrograms. This dose is based on the fact that the twin who is Rh positive has already received an anti-D prophylaxis, so the mother does not need to receive the full dose of 900 micrograms.\n\n"}, {"question": "An 8-year-old girl is brought by her mother to her pediatrician\u2019s office for a follow-up visit. She was diagnosed with asthma about 4 years ago and has been on medications ever since. She came into the doctor\u2019s office about a month ago with an escalation of her symptoms. She told her doctor that she has been struggling to breathe almost every single day. This difficulty increased when she played outdoors with her friends. She said that she used to wake up at least 3 times a week from sleep to use her inhaler. She uses a short-acting \u03b2-agonist inhaler to control her symptoms. At the previous visit, her doctor had started her on a small dose of fluticasone (inhaled) as well as a long-acting \u03b2-agonist inhaler. She has some improvement in her symptoms. On physical examination, she doesn\u2019t seem to be in distress, and currently, the lungs are clear on auscultation. Her forced expiratory volume in one second is about 70% of the predicted value. Based on the description of these patients symptoms and current treatment regime, which of the following categories describes the severity of this child\u2019s symptoms?", "correct_answer": "Moderate persistent", "correct_idx": 2, "options": ["A)Mild intermittent", "B)Mild persistent", "C)Moderate persistent", "D)Severe persistent"], "prompt": "An 8-year-old girl is brought by her mother to her pediatrician\u2019s office for a follow-up visit. She was diagnosed with asthma about 4 years ago and has been on medications ever since. She came into the doctor\u2019s office about a month ago with an escalation of her symptoms. She told her doctor that she has been struggling to breathe almost every single day. This difficulty increased when she played outdoors with her friends. She said that she used to wake up at least 3 times a week from sleep to use her inhaler. She uses a short-acting \u03b2-agonist inhaler to control her symptoms. At the previous visit, her doctor had started her on a small dose of fluticasone (inhaled) as well as a long-acting \u03b2-agonist inhaler. She has some improvement in her symptoms. On physical examination, she doesn\u2019t seem to be in distress, and currently, the lungs are clear on auscultation. Her forced expiratory volume in one second is about 70% of the predicted value. Based on the description of these patients symptoms and current treatment regime, which of the following categories describes the severity of this child\u2019s symptoms?A)Mild intermittent\nB)Mild persistent\nC)Moderate persistent\nD)Severe persistent", "subject_name": null, "output0": "The child\u2019s symptoms are described as difficulty breathing almost every single day, which is a mild persistent symptom. Additionally, the fact that she has been experiencing these symptoms for about 4 years and has been on medication for most of that time indicates that her symptoms are mild to moderate in severity. The fact that she has some improvement in her symptoms with the current treatment regime also supports the mild intermittent category.\n\n", "output1": "The child\u2019s symptoms of asthma are described as almost every single day, which indicates a moderate level of severity. Additionally, the fact that she is using a short-acting \u03b2-agonist inhaler and has been started on a long-acting \u03b2-agonist inhaler suggests that her symptoms are not mild, but rather mild persistent.\n\n", "output2": "The child\u2019s symptoms of difficulty breathing almost every day, waking up at least 3 times a week to use her inhaler, and the fact that she has been on medication for 4 years suggest that her symptoms are moderately persistent. Additionally, her forced expiratory volume in one second being 70% of the predicted value indicates that her lung function is moderately impaired. These factors all contribute to the child\u2019s symptoms being classified as moderate persistent.\n\n", "output3": "The child\u2019s symptoms of difficulty breathing almost every day, waking up at least 3 times a week to use her inhaler, and a forced expiratory volume in one second of 70% of the predicted value indicate a severe persistent asthma condition. The fact that she has been experiencing these symptoms for several years and has been on medication for asthma for four years also supports this categorization.\n\n"}]